VativoRx CEO, Lisa Quarterman, discusses innovative revenue solutions for healthcare organizations in Solutions Spotlight series

VativoRx CEO, Lisa Quarterman, discusses innovative revenue solutions for healthcare organizations in Solutions Spotlight series

Our CEO, Lisa Quarterman, recently joined the Solutions Spotlight series to chat with HAPevolve President Joe Tibbs. In this series, Lisa explains how VativoRx can help deliver additional revenue to hospitals, outpatient facilities, and other healthcare organizations without any additional expense or changes to their contracts.

VativoRx is an exclusive vendor for the Hospital and Healthsystem Association of Pennsylvania (HAP). HAPevolve identifies and creates valuable partnerships with a variety of businesses serving the healthcare community. By negotiating with its industry and endorsed partners on behalf of the Pennsylvania hospital and healthcare community at large, HAPevolve can offer members special benefits and discounts on innovative solutions that can save them both time and money.

Biosimilars — Similar But Not Identical

You may have never heard of biosimilar drugs and that’s probably because they are not commonly prescribed in the United States even though they have been around for over 20 years. So, what are biosimilar drugs? A biosimilar drug is no different in terms of safety and effectiveness than a biologic product, also known as a reference product, and while highly similar it is not identical.

Read More »

Lower Cost Prescription Drugs from Canada, Is It Legal?

In the early 2000s, the FDA set up guidelines in the Regulatory Procedures Manual (RPM) that permitted prescription drugs to be imported from other countries if the patient met very strict guidelines. Just stating that the patient needed the drug due to cost savings was not a justification to obtain the drug.

Read More »